FAQs

1. • What topics are covered at the Alzheimer's Disease & Cognitive Disorders Symposium?

     See hmpglobalevents.com/adcdsymposium/agenda. The agenda is still being finalized. It will focus on timely, practice-relevant education in Alzheimer's disease and related cognitive disorders. Past topics have included early recognition and differential diagnosis, cognitive assessment tools, biomarker-informed evaluation, disease-modifying and emerging therapies, neuropsychiatric symptom management, prevention and brain health strategies, caregiver integration, and case-based approaches to real-world patient care. The program is designed to help clinicians stay current on the evolving Alzheimer's care landscape while gaining practical insights they can apply across specialties.

   • Who should attend the Alzheimer's Disease & Cognitive Disorders Symposium?

     ADCD is designed for healthcare professionals involved in the care of patients with Alzheimer's disease, dementia, and other cognitive disorders. Attendees may include neurologists, psychiatrists, geriatricians, primary care clinicians, nurse practitioners, physician associates, nurses, and other members of the multidisciplinary care team. The symposium is especially valuable for clinicians looking for timely education, practical guidance, and cross-specialty perspectives.

   • What makes ADCD different from other Alzheimer's and dementia CE events?

     ADCD is designed to be timely, practical, and clinically relevant. Rather than focusing only on high-level theory, the symposium emphasizes real-world application, multidisciplinary discussion, and the latest developments shaping Alzheimer's and dementia care right now. Attendees gain focused education, actionable insights, and the opportunity to learn from experts and peers across specialties in a setting built around today’s most important questions in cognitive care.